FDA Warns Parents Against Amber Teething Necklaces and Bracelets

The U.S. Food and Drug Administration says getting teeth adornments is a gagging and strangulation peril for children and babies.

The U.S. Food and Drug Administration issued a notice Thursday about the hazard getting teeth pieces of jewelry posture to infants and little children.

The adornments — including pieces of jewelry and wrist trinkets worn by infants who are getting teeth, or utilized as tactile incitement for youngsters with mental imbalance or consideration shortage/hyperactivity issue — has been known to genuinely harm or execute kids, the FDA said in an announcement coordinated at guardians, parental figures and social insurance suppliers.

Accessories, armlets and anklets present strangulation dangers, and if the string breaks, kids can swallow globules and gag on them.

Reports incorporated a 18-month-old baby who kicked the bucket subsequent to being choked by his golden getting teeth neckband while resting, the FDA said. A 7-month-old child allegedly stifled on the dabs of a wooden getting teeth wrist trinket and must be taken to the healing facility.

“We’re worried about the dangers we’ve seen with these items and need guardians to know that getting teeth adornments puts kids, incorporating those with uncommon necessities, in danger of genuine damage and demise,” FDA Commissioner Scott Gottlieb, M.D., said in an announcement.

The dabs of getting teeth adornments might be made of silicone, wood, or different materials, including golden. The producers of golden getting teeth pieces of jewelry guarantee that a child’s body temperature warms the golden, discharging a torment alleviating compound that can be consumed through their skin to ease getting teeth torment.

What’s more, for sure, that substance, called succinate or succinic corrosive, has been appeared to have some remedial advantages. In any case, the FDA has not tried the accessory makers’ cases for security or viability.

Dr. Jaime Friedman, a San Diego-based pediatrician, applauded the FDA for issuing the notice. Friedman says that guardians once in a while request her recommendation on these getting teeth pieces of jewelry before they get one for their infant, however she as often as possible sees patients wearing them amid arrangements.

Friedman makes it a point to guide parental figures from utilizing them by raising gagging and strangulation dangers, and additionally the obscure impacts about the golden itself.

“I have not, starting at yet, seen that there’s any proof of [succinic] corrosive in the circulatory system,” she said. “Regardless of whether you do have this corrosive in the circulation system, do we realize what it’s doing? No, I don’t figure we do.”

Friedman, who is an official representative for the American Academy of Pediatrics and partnered with Children’s Primary Care Medical Group, said that if guardians demand utilizing the pieces of jewelry, she encourages them to not give babies a chance to wear them unsupervised. That implies no adornments while they rest, or while sitting in a vehicle situate if a grown-up can’t see them.

“I get it’s spontaneous exhortation, yet hello, that is my activity right? To secure children,” she said. “So I will continue doing it.”

The FDA has taken a solid position against other at-home getting teeth torment cures, including desensitizing gels or creams for gums, and homeopathic getting teeth tablets that were found to contain belladonna, a harmful plant that can be risky to individuals.

The American Academy of Pediatrics suggests that parental figures give their children a therapeutic ring that has been chilled in the refrigerator to numb the agony. Be that as it may, it cautions against solidifying therapeutic rings, as solidified rings can harm gums. Another protected choice for guardians would be for them to utilize a spotless finger to delicately rub or back rub their child’s gums.

On the off chance that you are aware of youngsters who have been harmed from getting teeth adornments, the FDA invites reports about what occurred at 1-800-FDA-1088 or online at their unfavorable occasion revealing website.


Hope Springs as New Alzheimer’s Medication Reaches Trial Stage

Medical experts are “cautiously optimistic” as a promising experimental drug aimed to slow down the progression of Alzheimer’s disease has reached its trial stage and is showing improved cognition and reduced clinical signs among those who participated in the study.

“These were people with very mild impairments, some confusion, forgetting someone’s name on occasion. That’s the goal: to stop Alzheimer’s disease when it’s in the mildest presentation,” said Dr. Lynn Kramer, the chief clinical and medical officer for Eisai in a CNN report.

The same report stated that the an anti-amyloid antibody medication, dubbed as BAN2401, has “not only reduced the formulation of new beta amyloid clusters in the brain, it reduced existing clusters by 70% on average.”

Kramer, in a Washington Post report, said that this, too, “is the first late-stage anti-amyloid antibody study to successfully achieve statistically significant results at 18 months, further validating the amyloid hypothesis.”

In the United States, over 5.7 million Americans aged 65 and up are said to have Alzheimer’s though experts have long said that this is not a normal part of aging. The Washington Post said the number of those diagnosed with Alzheimers could “mushroom to nearly 14 million by 2050 in the absence of new treatments.”

It is also currently the sixth leading cause of death in the US.

Alzheimer’s is a type of dementia that causes deterioration of memory, thinking and, at times, even behavior. Alzheimer’s Association said this usually develops “slowly and get worse over time, becoming severe enough to interfere with daily tasks.”

“I think it’s a big deal, because we’ve definitely had some disappointments in Alzheimer’s drug development lately, so I think we just need some positive news. We’re obviously very hopeful,” said James Hendrix, director of global science initiatives at the Alzheimer’s Association.

However, Keith Fargo, director of scientific programs at the Alzheimer’s Association, said the Food and Drugs Administration’s approval will be secured once the said medication will show the same promising results in the next larger trial.

“You are not going to be able to go to the doctor and get this anytime soon,” Fargo said.


Health Professionals Hail FDA Approval of Treatment for Excessive Drooling Adults with Neurological Disorders

The medical community has recently hailed the Food and Drugs Administration over its decision to approve treatments for adult patients with neurological disorders who experience excessive drooling, a report read.

“This approval represents a significant milestone in addressing the unmet needs for more than 600,000 adults who suffer from chronic sialorrhea, and underscores our commitment to improving the lives of those living with movement disorders,” said Kevin O’Brien, vice president and US Head of Neurosciences for Merz North America in a report.

For the longest time, health professionals have been pushing for the treatment of excessive drooling for adults with neurological disorders such as cerebral palsy, describing it as a “distressing symptom.”

A report said that certain medical conditions can put one at risk for drooling. FDA has reportedly approved the supplemental Biologics License Application (sBLA) for incobotulinumtoxinA (Xeomin, Merz North America) for excessive drooling.

IncobotulinumtoxinA is also reportedly the first and only neurotoxin approved for this indication in the United States, the report added. It is administered by injection into the muscles or glands.

“If a disease that decreases control of facial muscles affects you, you are more likely to drool. Neurologic disorders such as cerebral palsy, Parkinson’s disease, amyotrophic lateral sclerosis, or stroke may cause muscle weakness that affects the ability to close the mouth and swallow saliva,” a Health Line report read.

Another report revealed that execessive drooling is also a common non-motor symptom for patients who are afflicted with Parkinson’s Disease.

Excessive drooling among children with neurological disorders have also been reported in the past, adding that, “children with saliva management issues can present with over secretion of saliva, poor oral motor abilities, inappropriate posture, weak swallow reflects or limited sensitivity awareness of what is wet and what is dry.”

“If patients have drooling, they might subsequently spill saliva from their oral cavity, or might aspirate the saliva causing aspiration pneumonia,” a study revealed.

For the longest time, behavioral therapy and speech therapy have been used to address excessive drooling.